Explore the categories so you can find more about your search.

Categorie > Cardiovascular / Cardiology

PLx Pharma Demonstrates Bioequivalence With Aspirin And PL 2100 -- Aspirin-PC

Categorie : Cardiovascular / Cardiology
PLx Pharma Inc. announced that it has successfully completed a clinical trial of PL 2100, also known as Aspirin-PC and demonstrated its bioequivalence with regular aspirin. This trial demonstrates PL 2100 Aspirin-PC may bridge to the safety and efficacy of aspirin for prescription (Rx) treatment and ...

read more PLx Pharma Inc. announced that it has successfully completed a clinical trial of PL 2100, also known as Aspirin-PC and demonstrated its bioequivalence with regular aspirin. This trial demonstrates PL 2100 Aspirin-PC may bridge to the safety and efficacy of aspirin for prescription (Rx) treatment and read more Thu Jun 2008 Thu Jun 2008

Unique Bi-Directional Irrigated Tip Cardiac Catheter For Treatment Of Irregular Heart Rhythms Now Available In The European Union

Categorie : Cardiovascular / Cardiology
Patients in the European Union (EU) with arrhythmias, also known as irregular heart rhythms, may now benefit from treatment with a new state-of-the art catheter, designed to reduce char and thrombus formation during ablation and give physicians improved range of motion during procedures to eliminate ...

read more Patients in the European Union (EU) with arrhythmias, also known as irregular heart rhythms, may now benefit from treatment with a new state-of-the art catheter, designed to reduce char and thrombus formation during ablation and give physicians improved range of motion during procedures to eliminate read more Thu Jun 2008 Thu Jun 2008

Rasilez ASPIRE HIGHER Clinical Program Expands To 35,000 Patients In 14 Trials, The Largest Cardio-Renal Outcomes Program Ever

Categorie : Cardiovascular / Cardiology
Novartis announced details of two new long-term outcome studies in its landmark ASPIRE HIGHER clinical trial program which has expanded to involve more than 35,000 patients in 14 trials. The series of trials that comprise ASPIRE HIGHER now form the largest and most far-reaching cardio-renal outcome ...

read more Novartis announced details of two new long-term outcome studies in its landmark ASPIRE HIGHER clinical trial program which has expanded to involve more than 35,000 patients in 14 trials. The series of trials that comprise ASPIRE HIGHER now form the largest and most far-reaching cardio-renal outcome read more Thu Jun 2008 Thu Jun 2008

Hybrid Cardiac Catheterization Suite Combines Non Surgical And Surgical Treatments For Heart Defects

Categorie : Cardiovascular / Cardiology
A new cardiac treatment facility that couples the benefits of interventional cardiology with cardiothoracic surgery for critically ill newborns, children and adults has opened at Rush University Medical Center. ...

read more A new cardiac treatment facility that couples the benefits of interventional cardiology with cardiothoracic surgery for critically ill newborns, children and adults has opened at Rush University Medical Center. read more Thu Jun 2008 Thu Jun 2008

Appropriate Aspirin Use For Prevention Of Heart Disease And Stroke - American Medical Association

Categorie : Cardiovascular / Cardiology
The American Medical Association (AMA), the nation's largest physician group, voted at its Annual Meeting to adopt the following new policy.Six trials, involving more than 95,000 adult men and women, have shown aspirin may be effective in reducing the risk of heart attack and stroke. The AMA today p ...

read more The American Medical Association (AMA), the nation's largest physician group, voted at its Annual Meeting to adopt the following new policy.Six trials, involving more than 95,000 adult men and women, have shown aspirin may be effective in reducing the risk of heart attack and stroke. The AMA today p read more Thu Jun 2008 Thu Jun 2008

First Gene Therapy For Heart Failure Offered At Medical Center

Categorie : Cardiovascular / Cardiology
Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.NewYork-Presbyterian Hospital/Columbia Uni ...

read more Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.NewYork-Presbyterian Hospital/Columbia Uni read more Thu Jun 2008 Thu Jun 2008

Cardiologists Use Magnetic Navigation To Guide Heart Catheter Procedures

Categorie : Cardiovascular / Cardiology
Loyola University Hospital has become the first Chicago-area hospital to treat heart problems with a magnetically guided catheter that's much more precise than manual catheters -- and easier on the heart.The Gentle Touch? catheter has a metal tip. It is guided by two computer-controlled magnets, one ...

read more Loyola University Hospital has become the first Chicago-area hospital to treat heart problems with a magnetically guided catheter that's much more precise than manual catheters -- and easier on the heart.The Gentle Touch? catheter has a metal tip. It is guided by two computer-controlled magnets, one read more Thu Jun 2008 Thu Jun 2008

Cook Medical Enters Coronary Stent Market In Europe With New CoCr Stent

Categorie : Cardiovascular / Cardiology
Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal coronary stent that company executives believe will fill a demand for non-drug eluting coronary stents among interventional cardiologists, the company announced today. The dev ...

read more Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal coronary stent that company executives believe will fill a demand for non-drug eluting coronary stents among interventional cardiologists, the company announced today. The dev read more Thu Jun 2008 Thu Jun 2008

New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored In Large Patient Registry

Categorie : Cardiovascular / Cardiology
Registry data for more than 500 patients presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting show deep vein thrombosis (DVT) treatment with the Trellis device breaks up a blood clot in most patients much quicker than using a drug alone. Using imaging, the device ...

read more Registry data for more than 500 patients presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting show deep vein thrombosis (DVT) treatment with the Trellis device breaks up a blood clot in most patients much quicker than using a drug alone. Using imaging, the device read more Tue Mar 2008 Tue Mar 2008

Breakthrough Treatment For Severe Frostbite Saves Limbs

Categorie : Cardiovascular / Cardiology
Using imaging to visualize areas lacking blood flow and deliver drugs via catheter, interventional radiologists are reopening recently frozen, clotted arteries with clot-busting and anti-spasmodic drugs. The people in a recent prospective trial had severely frostbitten hands and feet (with tissue fr ...

read more Using imaging to visualize areas lacking blood flow and deliver drugs via catheter, interventional radiologists are reopening recently frozen, clotted arteries with clot-busting and anti-spasmodic drugs. The people in a recent prospective trial had severely frostbitten hands and feet (with tissue fr read more Tue Mar 2008 Tue Mar 2008

First Patient Enrolled In SONIC I Registry Of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System

Categorie : Cardiovascular / Cardiology
OmniSonics Medical Technologies, Inc., a developer of advanced medical devices for use in the treatment of vascular disease, announced that it has enrolled its first patient in the SONIC I Clinical Registry. SONIC I is a prospective, multi-centered U.S. registry study of the company's OmniWave(TM) ...

read more OmniSonics Medical Technologies, Inc., a developer of advanced medical devices for use in the treatment of vascular disease, announced that it has enrolled its first patient in the SONIC I Clinical Registry. SONIC I is a prospective, multi-centered U.S. registry study of the company's OmniWave(TM) read more Tue Mar 2008 Tue Mar 2008

Age Could Be Modifiable Risk Factor In Heart Disease

Categorie : Cardiovascular / Cardiology
Age is currently considered an unmodifiable risk factor in thedevelopment of cardiovascular disease -- but it might not need to be.According to the authors of a Viewpoint published on March 4, 2008 inThe Lancet, age can be broken down into factorswhich are indeed"unstoppable," but also into factors ...

read more Age is currently considered an unmodifiable risk factor in thedevelopment of cardiovascular disease -- but it might not need to be.According to the authors of a Viewpoint published on March 4, 2008 inThe Lancet, age can be broken down into factorswhich are indeed read more Tue Mar 2008 Tue Mar 2008

Study Links Protein To Risk Of Heart Disease

Categorie : Cardiovascular / Cardiology
A new study published in the Journal of the American MedicalAssociation reports that there is an association between thegene for the HDL-associated protein paraoxonase 1 (PON1) and adversecardiac events such as coronary artery disease.Researcher Stanley L. Hazen, M.D., Ph.D (Cleveland Clinic) andcol ...

read more A new study published in the Journal of the American MedicalAssociation reports that there is an association between thegene for the HDL-associated protein paraoxonase 1 (PON1) and adversecardiac events such as coronary artery disease.Researcher Stanley L. Hazen, M.D., Ph.D (Cleveland Clinic) andcol read more Tue Mar 2008 Tue Mar 2008

Improved Foam For Varicose Veins Found To Be Safe In Preliminary Results From Phase II Trial

Categorie : Cardiovascular / Cardiology
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial. The results were presented in Washington, ...

read more A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial. The results were presented in Washington, read more Tue Mar 2008 Tue Mar 2008

NICE Guideline On Prophylaxis For Infective Endocarditis Set To Change Current Clinical Practice

Categorie : Cardiovascular / Cardiology
The National Institute for Health and Clinical Excellence (NICE) has today issued a clinical guideline on antibiotic prophylaxis against infective endocarditis (IE). In a significant change to current clinical practice, the guideline recommends that antibiotics to prevent IE should not be given to a ...

read more The National Institute for Health and Clinical Excellence (NICE) has today issued a clinical guideline on antibiotic prophylaxis against infective endocarditis (IE). In a significant change to current clinical practice, the guideline recommends that antibiotics to prevent IE should not be given to a read more Tue Mar 2008 Tue Mar 2008

Cedars-Sinai Heart Institute Now Enrolling Women With Recurrent Chest Pains For Aware Clinical Trial

Categorie : Cardiovascular / Cardiology
The Cedars-Sinai Heart Institute is recruiting female patients with recurrent chest pains who are not eligible for surgery to participate in a clinical trial studying an experimental product designed to promote blood vessel growth within the heart muscle. ...

read more The Cedars-Sinai Heart Institute is recruiting female patients with recurrent chest pains who are not eligible for surgery to participate in a clinical trial studying an experimental product designed to promote blood vessel growth within the heart muscle. read more Tue Mar 2008 Tue Mar 2008

Abbott Receives CE Mark For Smaller Size XIENCE? V Drug Eluting Stent

Categorie : Cardiovascular / Cardiology
Abbott announced that it has received CE Mark (Conformité Européene) approval for a 2.25 mm version of its XIENCE? V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of XIENCE V. The a ...

read more Abbott announced that it has received CE Mark (Conformité Européene) approval for a 2.25 mm version of its XIENCE? V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of XIENCE V. The a read more Mon Mar 2008 Mon Mar 2008

Black Glaucoma Patients Have An Increased Risk Of Cardiovascular Disease Death, Study Finds

Categorie : Cardiovascular / Cardiology
Blacks who have been diagnosed and treated for glaucoma have an increased risk of death from cardiovascular disease, particularly those who receive certain eye drops for treatment of open-angle glaucoma, according to a study published in the March issue of Archives of Ophthalmology, Reuters reports. ...

read more Blacks who have been diagnosed and treated for glaucoma have an increased risk of death from cardiovascular disease, particularly those who receive certain eye drops for treatment of open-angle glaucoma, according to a study published in the March issue of Archives of Ophthalmology, Reuters reports. read more Mon Mar 2008 Mon Mar 2008

Family Cardiac Caregivers May Have Higher Heart Disease Risk

Categorie : Cardiovascular / Cardiology
Caring for a family member with a serious heart ailment may increase your risk of cardiac disease, according to a report presented at the American Heart Association's 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. ...

read more Caring for a family member with a serious heart ailment may increase your risk of cardiac disease, according to a report presented at the American Heart Association's 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. read more Mon Mar 2008 Mon Mar 2008

Drinking In Middle Age And Heart Risk

Categorie : Cardiovascular / Cardiology
The Daily Mail reports that "teetotallers may finally have a reason to enjoy the odd tipple - a new [study] shows non-drinkers who begin drinking in middle-age live longer and are less likely to develop heart disease." The Daily Mirror also covers the story and says that researchers have found that ...

read more The Daily Mail reports that read more Mon Mar 2008 Mon Mar 2008

<<< previous | 1 | 2 | 3 | 4 | 5 | 6 next >>>



     


Custom Search